Key facts
- This page summarizes Stelios Papadopoulos's Form 4 filing for EXELIXIS, INC. (EXEL).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 16 May 2025, 20:57.
Stelios Papadopoulos - 15 May 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- Director
- Issuer ticker
- EXEL
- Reported as of
- 15 May 2025
- Net transaction value
- -$885,779
- SEC form
- 4
- Accepted by SEC
- 16 May 2025, 20:57:50 UTC
- Prior SEC filing
- 30 Apr 2025
- Next SEC filing
- 30 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stelios Papadopoulos filed Form 4 for EXELIXIS, INC. (EXEL) on 16 May 2025.
Change
- Previous filing in this sequence was filed on 30 Apr 2025.
- Current net transaction value: -$885,779.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001202098
Primary reporting owner
PAPADOPOULOS STELIOS
- Relationship
- Director
- Address
- C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA
- Signature
- /s/ Nina Ayer, Attorney in Fact
- Signature date
- 16 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $407,934
- Shares
- +20,634
- Change %
- +1.6%
- Price
- $19.77
- Shares after
- 1,300,050
- Date
- 15 May 2025
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $915,118
- Shares
- -20,634
- Change %
- -1.6%
- Price
- $44.35
- Shares after
- 1,279,416
- Date
- 15 May 2025
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $325,417
- Shares
- +15,874
- Change %
- +1.2%
- Price
- $20.50
- Shares after
- 1,295,290
- Date
- 15 May 2025
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $704,012
- Shares
- -15,874
- Change %
- -1.2%
- Price
- $44.35
- Shares after
- 1,279,416
- Date
- 15 May 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,634
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,634
- Exercise price
- $19.77
- Footnotes
- F2
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,874
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,874
- Exercise price
- $20.50
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Footnote F2
The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
Footnote F3
The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.